Advocacy at a Glance 9/6/19 Advocacy at a Glance 9/6/19 Advocacy at a Glance Read More Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More Advocacy at a Glance 8/23/19 Advocacy at a Glance 8/23/19 Advocacy at a Glance Read More Analysis and Commentary 8/11/19 Analysis and Commentary 8/11/19 Angling for Optimism Read More Advocacy at a Glance 8/11/19 Advocacy at a Glance 8/11/19 Advocacy at a Glance Read More Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More Advocacy at a Glance 8/2/19 Advocacy at a Glance 8/2/19 Advocacy at a Glance Read More Analysis and Commentary 7/26/19 Analysis and Commentary 7/26/19 A Budget Deal Seems to Be in Place ... But There Are More Questions Read More Advocacy at a Glance 7/26/19 Advocacy at a Glance 7/26/19 Advocacy at a Glance Read More Analysis and Commentary 7/19/19 Analysis and Commentary 7/19/19 No Guarantees for a Bright Future Read More Advocacy at a Glance 7/19/19 Advocacy at a Glance 7/19/19 Advocacy at a Glance Read More Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More Advocacy at a Glance 7/12/19 Advocacy at a Glance 7/12/19 Advocacy at a Glance Read More Analysis and Commentary 6/29/19 Analysis and Commentary 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More Advocacy at a Glance 6/29/19 Advocacy at a Glance 6/29/19 Advocacy at a Glance Read More Analysis and Commentary 6/24/19 Analysis and Commentary 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More Advocacy at a Glance 6/24/19 Advocacy at a Glance 6/24/19 Advocacy at a Glance Read More Analysis and Commentary 5/31/19 Analysis and Commentary 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More Advocacy at a Glance 5/31/19 Advocacy at a Glance 5/31/19 Advocacy at a Glance Read More Analysis and Commentary 5/23/19 Analysis and Commentary 5/23/19 House Mark-up for FY 20 Very Pleasing Read More Newer Posts Older Posts
Analysis and Commentary 8/23/19 Analysis and Commentary 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More
Analysis and Commentary 8/2/19 Analysis and Commentary 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More
Analysis and Commentary 7/26/19 Analysis and Commentary 7/26/19 A Budget Deal Seems to Be in Place ... But There Are More Questions Read More
Analysis and Commentary 7/19/19 Analysis and Commentary 7/19/19 No Guarantees for a Bright Future Read More
Analysis and Commentary 7/12/19 Analysis and Commentary 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More
Analysis and Commentary 6/29/19 Analysis and Commentary 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More
Analysis and Commentary 6/24/19 Analysis and Commentary 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More
Analysis and Commentary 5/31/19 Analysis and Commentary 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More
Analysis and Commentary 5/23/19 Analysis and Commentary 5/23/19 House Mark-up for FY 20 Very Pleasing Read More
